do you lose weight the first week on tirzepatide Where Tirzepatide? How Does Tirzepatide Work for

Focus on good nutrition, sleep, and stress management to maximize weight loss

This novel drug offe

Recent studies link semaglutide (Ozempic, Wegovy) to a rare risk of non-arteritic anterior ischemic optic neuropathy (NAION)

The STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial programme demonstrated that adults using semaglutide 2.4 mg weekly alongside lifestyle intervention lost an average of approximately 15% of their body weight over 68 weeks, compared to around 2.4% with placebo. NICE approved Wegovy for use in specialist weight management services in the UK in 2023 (TA875), recognising its clinical effectiveness. Ongoing research continues to explore its cardiovascular benefits, with the SELECT trial showing a significant reduction in major cardiovascular events in people with obesity

While newly approved pharmacotherapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) show efficacy, their clinical utility remains constrained by dose-dependent gastrointestinal complications, underscoring the urgent need for safer alternatives